Sestamibi
- Product NDC
- 51808-208
- 11-digit product format
- 518080208
- Labeler code
- 51808
- Product ID
- 51808-208_118e6927-25b5-4bcc-8716-fcb5dbdc487b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sestamibi
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- AnazaoHealth Corporation
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2012-05-23
- Marketing end
- 0000-00-00
- Substance
- TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
- Active strength
- 2 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51808-208-01 | Sestamibi | 1 in 1 KIT | INJECTION, POWDER, LYOPHILIZED, | 1 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE | ACTIVE INGREDIENT | N6OU7HJ70P | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE | ACTIVE MOIETY | N6OU7HJ70P | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| CYSTEINE HYDROCHLORIDE | INACTIVE INGREDIENT | ZT934N0X4W | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| STANNOUS CHLORIDE | INACTIVE INGREDIENT | 1BQV3749L5 | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51808-208 | SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ANAZAOHEALTH CORPORATION] | 1 | Legacy NDC, 1 package rows | 20121015_5ef52f7c-042e-4f84-8048-5249bd01fade.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 51808-208-01 | 51808020801 | 1 in 1 KIT | Historical |